Abstract
ObjectiveWe aimed to explore the expression level and biological function of miR-145–5p in preeclampsia (PE). MethodsThe differentially expressed miRNA/mRNA between normal placentas and PE placentas were screened using the GSE84260 and GSE73374 datasets from the Gene Expression Omnibus Database. The expression of miR-145–5p in PE placentas was detected by qRT-PCR. The CCK-8 assay, wound healing and transwell were carried out to determine the cell growth, migration and invasion when miR-145–5p was overexpressed or inhibited. The real-time quantitative PCR (qRT-PCR), Western Blot and dual-luciferase reporter assays were conducted to preliminarily explore possible mechanisms. ResultsA total of 33 miRNAs were found significantly differentially expressed in PE patients, 19 were significantly upregulated and 14 were significantly downregulated. The relative miR-145–5p expression was lower in PE placentas than normal placentas. The viability and invasion were suppressed when miR-145–5p was inhibited in trophoblasts cells, while miR-145–5p overexpression promoted the effectiveness. In addition, mRNA and protein expression of FLT1 in HTR-8/SVneo cell was also downregulated with miR-145–5p overexpression, suggesting that FLT1 is the target gene of miR-145–5p. Consistent with miR-145–5p overexpression, the mRNA and protein expression of FLT1 also were upregulated with miR-145–5p interference. Furthermore, the expression of miR-145–5p was regulated by the Hypoxic conditions. ConclusionsIn conclusion, the results showed miR-145–5p may participate in PE development by affecting the proliferation and invasion of trophoblast cells. This is a new perspective to understand the etiology and pathogenesis of PE, which may provide a new breakthrough for the early prediction and diagnosis of PE.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.